The capabilities of smartwatches are still very much evolving, and in recent years thoughts have turned to the possibility of using them as medical devices.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh